Sound Bioventures
Ester Sklarsky is a seasoned professional in the life sciences and biotechnology sectors with a robust background in investment and management consulting. Currently serving as Principal at Sound Bioventures since February 2022, Ester also holds positions as a Board Observer at ARTHEx Biotech and Artax Biopharma Inc. Prior experience includes roles at Industrifonden, Sirona Health Solutions, and DNB Markets, where Ester contributed as an Associate, Management Consultant, and Equity Analyst, respectively. With a strong foundation in medical science, Ester holds a Master of Medical Science in Bioentrepreneurship and a Bachelor of Science in Biomedicine from Karolinska Institutet, alongside ongoing education at UNSW and KTH Royal Institute of Technology.
This person is not in any teams
Sound Bioventures
Sound Bioventures is a Venture Capital firm that Invests in private clinical stage biotherapeutics companies in Europe and USA. The fund has a geographic footprint on both sides of the Atlantic and will support the clinical development of novel medicines for diseases of high unmet medical need.